Abstract
BackgroundConsidering that most semantic dementia (SD) and frontotemporal dementia (FTD) patients show no post-mortem Alzheimer's disease (AD) pathology, cerebrospinal fluid (CSF) biomarkers may be of value for distinguishing these patients...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have